Eton Pharmaceuticals, Inc. (ETON): Form 8-K filed 2026-10-14

Items reported

Item 1.01: Entry into a Material Definitive Agreement
The company signed a material agreement outside the ordinary course of business, or materially amended one. Typical examples are credit agreements, merger agreements, large supply or licensing contracts and financing arrangements.
Item 2.01: Completion of Acquisition or Disposition of Assets
The company completed the acquisition or disposition of a significant amount of assets, including a business. The report covers the date, the assets, the counterparty and the consideration.
Item 9.01: Financial Statements and Exhibits
Lists the financial statements, pro forma information and exhibits filed with the report. It almost always accompanies another Item and is rarely news on its own.

Type	Description	Document
8-K	FORM 8-K	eton20261013_8k.htm
EX-99.1	EXHIBIT 99.1 PRESS RELEASE RELATING TO LIBERVANT LICENSING AGREEEMENT	ex_1025429.htm

This page lists what the filing reports; it does not summarize or interpret it. Read the original documents on SEC EDGAR. How to read an 8-K.